KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.49
Delayed Data
As of Mar 31
 +0.001 / +0.20%
Today’s Change
0.36
Today|||52-Week Range
2.80
-71.68%
Year-to-Date
No recent news for KaloBios Pharmaceuticals Inc.

Today’s Trading

Previous close0.49
Today’s open0.49
Day’s range0.46 - 0.50
Volume191,800
Average volume (3 months)1,441,219
Market cap$16.1M
Dividend yield--
Data as of 3:59pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+33.53%
Earnings growth (this year)-7.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc+0.03+3.96%
RTGNRuthigen Inc+0.04+1.18%
OPXAOpexa Therapeutics I...+0.02+3.68%
DARADARA BioSciences Inc-0.03-3.83%
Data as of 3:59pm ET, 03/31/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$38.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive &
Financial Officer
Herbert C. Cross
CSO, Executive VP-Research &
Development
Geoffrey Thomas Yarranton
Corporate headquarters
South San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account